Medical Care
Global AQP4 Antibody Market Research Report 2025
- May 12, 25
- ID: 234911
- Pages: 100
- Figures: 99
- Views: 29
The global market for AQP4 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
AQP4 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target AQP4 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel AQP4 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AQP4 antibody market revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AQP4 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AQP4 Antibody.
The AQP4 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AQP4 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AQP4 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Atlas Antibodies
Boster Bio
Absolute Antibody
VWR
Alomone Labs
Synaptic Systems
St John's Laboratory
Abcam
Cell Signaling Technology
ABclonal
Nordic BioSite
Merck
LifeSpan BioSciences
Bioss
Novus Biologicals
RayBiotech
Abnova Corporation
Beijing Solarbio
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Western Blot (WB)
Immunochemistry (IHC)
Immunoprecipitation (IP)
Immunocytochemistry (ICC)
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of AQP4 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of AQP4 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
AQP4 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target AQP4 in human, mouse, rat, rabbit and pig samples.
Growing patient base, launch of novel AQP4 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AQP4 antibody market revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AQP4 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AQP4 Antibody.
The AQP4 Antibody market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AQP4 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AQP4 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Atlas Antibodies
Boster Bio
Absolute Antibody
VWR
Alomone Labs
Synaptic Systems
St John's Laboratory
Abcam
Cell Signaling Technology
ABclonal
Nordic BioSite
Merck
LifeSpan BioSciences
Bioss
Novus Biologicals
RayBiotech
Abnova Corporation
Beijing Solarbio
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Western Blot (WB)
Immunochemistry (IHC)
Immunoprecipitation (IP)
Immunocytochemistry (ICC)
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of AQP4 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of AQP4 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 AQP4 Antibody Market Overview
1.1 Product Definition
1.2 AQP4 Antibody by Type
1.2.1 Global AQP4 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 AQP4 Antibody by Application
1.3.1 Global AQP4 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Western Blot (WB)
1.3.3 Immunochemistry (IHC)
1.3.4 Immunoprecipitation (IP)
1.3.5 Immunocytochemistry (ICC)
1.3.6 Others
1.4 Global AQP4 Antibody Market Size Estimates and Forecasts
1.4.1 Global AQP4 Antibody Revenue 2020-2031
1.4.2 Global AQP4 Antibody Sales 2020-2031
1.4.3 Global AQP4 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 AQP4 Antibody Market Competition by Manufacturers
2.1 Global AQP4 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global AQP4 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global AQP4 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of AQP4 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of AQP4 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of AQP4 Antibody, Product Type & Application
2.7 Global Key Manufacturers of AQP4 Antibody, Date of Enter into This Industry
2.8 Global AQP4 Antibody Market Competitive Situation and Trends
2.8.1 Global AQP4 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest AQP4 Antibody Players Market Share by Revenue
2.8.3 Global AQP4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global AQP4 Antibody Market Scenario by Region
3.1 Global AQP4 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global AQP4 Antibody Sales by Region: 2020-2031
3.2.1 Global AQP4 Antibody Sales by Region: 2020-2025
3.2.2 Global AQP4 Antibody Sales by Region: 2026-2031
3.3 Global AQP4 Antibody Revenue by Region: 2020-2031
3.3.1 Global AQP4 Antibody Revenue by Region: 2020-2025
3.3.2 Global AQP4 Antibody Revenue by Region: 2026-2031
3.4 North America AQP4 Antibody Market Facts & Figures by Country
3.4.1 North America AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America AQP4 Antibody Sales by Country (2020-2031)
3.4.3 North America AQP4 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe AQP4 Antibody Market Facts & Figures by Country
3.5.1 Europe AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe AQP4 Antibody Sales by Country (2020-2031)
3.5.3 Europe AQP4 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific AQP4 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific AQP4 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific AQP4 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific AQP4 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America AQP4 Antibody Market Facts & Figures by Country
3.7.1 Latin America AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America AQP4 Antibody Sales by Country (2020-2031)
3.7.3 Latin America AQP4 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa AQP4 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa AQP4 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa AQP4 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global AQP4 Antibody Sales by Type (2020-2031)
4.1.1 Global AQP4 Antibody Sales by Type (2020-2025)
4.1.2 Global AQP4 Antibody Sales by Type (2026-2031)
4.1.3 Global AQP4 Antibody Sales Market Share by Type (2020-2031)
4.2 Global AQP4 Antibody Revenue by Type (2020-2031)
4.2.1 Global AQP4 Antibody Revenue by Type (2020-2025)
4.2.2 Global AQP4 Antibody Revenue by Type (2026-2031)
4.2.3 Global AQP4 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global AQP4 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global AQP4 Antibody Sales by Application (2020-2031)
5.1.1 Global AQP4 Antibody Sales by Application (2020-2025)
5.1.2 Global AQP4 Antibody Sales by Application (2026-2031)
5.1.3 Global AQP4 Antibody Sales Market Share by Application (2020-2031)
5.2 Global AQP4 Antibody Revenue by Application (2020-2031)
5.2.1 Global AQP4 Antibody Revenue by Application (2020-2025)
5.2.2 Global AQP4 Antibody Revenue by Application (2026-2031)
5.2.3 Global AQP4 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global AQP4 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Atlas Antibodies
6.1.1 Atlas Antibodies Company Information
6.1.2 Atlas Antibodies Description and Business Overview
6.1.3 Atlas Antibodies AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Atlas Antibodies AQP4 Antibody Product Portfolio
6.1.5 Atlas Antibodies Recent Developments/Updates
6.2 Boster Bio
6.2.1 Boster Bio Company Information
6.2.2 Boster Bio Description and Business Overview
6.2.3 Boster Bio AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boster Bio AQP4 Antibody Product Portfolio
6.2.5 Boster Bio Recent Developments/Updates
6.3 Absolute Antibody
6.3.1 Absolute Antibody Company Information
6.3.2 Absolute Antibody Description and Business Overview
6.3.3 Absolute Antibody AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Absolute Antibody AQP4 Antibody Product Portfolio
6.3.5 Absolute Antibody Recent Developments/Updates
6.4 VWR
6.4.1 VWR Company Information
6.4.2 VWR Description and Business Overview
6.4.3 VWR AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VWR AQP4 Antibody Product Portfolio
6.4.5 VWR Recent Developments/Updates
6.5 Alomone Labs
6.5.1 Alomone Labs Company Information
6.5.2 Alomone Labs Description and Business Overview
6.5.3 Alomone Labs AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alomone Labs AQP4 Antibody Product Portfolio
6.5.5 Alomone Labs Recent Developments/Updates
6.6 Synaptic Systems
6.6.1 Synaptic Systems Company Information
6.6.2 Synaptic Systems Description and Business Overview
6.6.3 Synaptic Systems AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synaptic Systems AQP4 Antibody Product Portfolio
6.6.5 Synaptic Systems Recent Developments/Updates
6.7 St John's Laboratory
6.7.1 St John's Laboratory Company Information
6.7.2 St John's Laboratory Description and Business Overview
6.7.3 St John's Laboratory AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 St John's Laboratory AQP4 Antibody Product Portfolio
6.7.5 St John's Laboratory Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Company Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abcam AQP4 Antibody Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 Cell Signaling Technology
6.9.1 Cell Signaling Technology Company Information
6.9.2 Cell Signaling Technology Description and Business Overview
6.9.3 Cell Signaling Technology AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cell Signaling Technology AQP4 Antibody Product Portfolio
6.9.5 Cell Signaling Technology Recent Developments/Updates
6.10 ABclonal
6.10.1 ABclonal Company Information
6.10.2 ABclonal Description and Business Overview
6.10.3 ABclonal AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ABclonal AQP4 Antibody Product Portfolio
6.10.5 ABclonal Recent Developments/Updates
6.11 Nordic BioSite
6.11.1 Nordic BioSite Company Information
6.11.2 Nordic BioSite Description and Business Overview
6.11.3 Nordic BioSite AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nordic BioSite AQP4 Antibody Product Portfolio
6.11.5 Nordic BioSite Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck AQP4 Antibody Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 LifeSpan BioSciences
6.13.1 LifeSpan BioSciences Company Information
6.13.2 LifeSpan BioSciences Description and Business Overview
6.13.3 LifeSpan BioSciences AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 LifeSpan BioSciences AQP4 Antibody Product Portfolio
6.13.5 LifeSpan BioSciences Recent Developments/Updates
6.14 Bioss
6.14.1 Bioss Company Information
6.14.2 Bioss Description and Business Overview
6.14.3 Bioss AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bioss AQP4 Antibody Product Portfolio
6.14.5 Bioss Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Company Information
6.15.2 Novus Biologicals Description and Business Overview
6.15.3 Novus Biologicals AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novus Biologicals AQP4 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 RayBiotech
6.16.1 RayBiotech Company Information
6.16.2 RayBiotech Description and Business Overview
6.16.3 RayBiotech AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RayBiotech AQP4 Antibody Product Portfolio
6.16.5 RayBiotech Recent Developments/Updates
6.17 Abnova Corporation
6.17.1 Abnova Corporation Company Information
6.17.2 Abnova Corporation Description and Business Overview
6.17.3 Abnova Corporation AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Abnova Corporation AQP4 Antibody Product Portfolio
6.17.5 Abnova Corporation Recent Developments/Updates
6.18 Beijing Solarbio
6.18.1 Beijing Solarbio Company Information
6.18.2 Beijing Solarbio Description and Business Overview
6.18.3 Beijing Solarbio AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Solarbio AQP4 Antibody Product Portfolio
6.18.5 Beijing Solarbio Recent Developments/Updates
6.19 Jingjie PTM BioLab
6.19.1 Jingjie PTM BioLab Company Information
6.19.2 Jingjie PTM BioLab Description and Business Overview
6.19.3 Jingjie PTM BioLab AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jingjie PTM BioLab AQP4 Antibody Product Portfolio
6.19.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 AQP4 Antibody Industry Chain Analysis
7.2 AQP4 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 AQP4 Antibody Production Mode & Process Analysis
7.4 AQP4 Antibody Sales and Marketing
7.4.1 AQP4 Antibody Sales Channels
7.4.2 AQP4 Antibody Distributors
7.5 AQP4 Antibody Customer Analysis
8 AQP4 Antibody Market Dynamics
8.1 AQP4 Antibody Industry Trends
8.2 AQP4 Antibody Market Drivers
8.3 AQP4 Antibody Market Challenges
8.4 AQP4 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 AQP4 Antibody by Type
1.2.1 Global AQP4 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 AQP4 Antibody by Application
1.3.1 Global AQP4 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Western Blot (WB)
1.3.3 Immunochemistry (IHC)
1.3.4 Immunoprecipitation (IP)
1.3.5 Immunocytochemistry (ICC)
1.3.6 Others
1.4 Global AQP4 Antibody Market Size Estimates and Forecasts
1.4.1 Global AQP4 Antibody Revenue 2020-2031
1.4.2 Global AQP4 Antibody Sales 2020-2031
1.4.3 Global AQP4 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 AQP4 Antibody Market Competition by Manufacturers
2.1 Global AQP4 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global AQP4 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global AQP4 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of AQP4 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of AQP4 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of AQP4 Antibody, Product Type & Application
2.7 Global Key Manufacturers of AQP4 Antibody, Date of Enter into This Industry
2.8 Global AQP4 Antibody Market Competitive Situation and Trends
2.8.1 Global AQP4 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest AQP4 Antibody Players Market Share by Revenue
2.8.3 Global AQP4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global AQP4 Antibody Market Scenario by Region
3.1 Global AQP4 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global AQP4 Antibody Sales by Region: 2020-2031
3.2.1 Global AQP4 Antibody Sales by Region: 2020-2025
3.2.2 Global AQP4 Antibody Sales by Region: 2026-2031
3.3 Global AQP4 Antibody Revenue by Region: 2020-2031
3.3.1 Global AQP4 Antibody Revenue by Region: 2020-2025
3.3.2 Global AQP4 Antibody Revenue by Region: 2026-2031
3.4 North America AQP4 Antibody Market Facts & Figures by Country
3.4.1 North America AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America AQP4 Antibody Sales by Country (2020-2031)
3.4.3 North America AQP4 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe AQP4 Antibody Market Facts & Figures by Country
3.5.1 Europe AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe AQP4 Antibody Sales by Country (2020-2031)
3.5.3 Europe AQP4 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific AQP4 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific AQP4 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific AQP4 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific AQP4 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America AQP4 Antibody Market Facts & Figures by Country
3.7.1 Latin America AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America AQP4 Antibody Sales by Country (2020-2031)
3.7.3 Latin America AQP4 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa AQP4 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa AQP4 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa AQP4 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa AQP4 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global AQP4 Antibody Sales by Type (2020-2031)
4.1.1 Global AQP4 Antibody Sales by Type (2020-2025)
4.1.2 Global AQP4 Antibody Sales by Type (2026-2031)
4.1.3 Global AQP4 Antibody Sales Market Share by Type (2020-2031)
4.2 Global AQP4 Antibody Revenue by Type (2020-2031)
4.2.1 Global AQP4 Antibody Revenue by Type (2020-2025)
4.2.2 Global AQP4 Antibody Revenue by Type (2026-2031)
4.2.3 Global AQP4 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global AQP4 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global AQP4 Antibody Sales by Application (2020-2031)
5.1.1 Global AQP4 Antibody Sales by Application (2020-2025)
5.1.2 Global AQP4 Antibody Sales by Application (2026-2031)
5.1.3 Global AQP4 Antibody Sales Market Share by Application (2020-2031)
5.2 Global AQP4 Antibody Revenue by Application (2020-2031)
5.2.1 Global AQP4 Antibody Revenue by Application (2020-2025)
5.2.2 Global AQP4 Antibody Revenue by Application (2026-2031)
5.2.3 Global AQP4 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global AQP4 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Atlas Antibodies
6.1.1 Atlas Antibodies Company Information
6.1.2 Atlas Antibodies Description and Business Overview
6.1.3 Atlas Antibodies AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Atlas Antibodies AQP4 Antibody Product Portfolio
6.1.5 Atlas Antibodies Recent Developments/Updates
6.2 Boster Bio
6.2.1 Boster Bio Company Information
6.2.2 Boster Bio Description and Business Overview
6.2.3 Boster Bio AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boster Bio AQP4 Antibody Product Portfolio
6.2.5 Boster Bio Recent Developments/Updates
6.3 Absolute Antibody
6.3.1 Absolute Antibody Company Information
6.3.2 Absolute Antibody Description and Business Overview
6.3.3 Absolute Antibody AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Absolute Antibody AQP4 Antibody Product Portfolio
6.3.5 Absolute Antibody Recent Developments/Updates
6.4 VWR
6.4.1 VWR Company Information
6.4.2 VWR Description and Business Overview
6.4.3 VWR AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VWR AQP4 Antibody Product Portfolio
6.4.5 VWR Recent Developments/Updates
6.5 Alomone Labs
6.5.1 Alomone Labs Company Information
6.5.2 Alomone Labs Description and Business Overview
6.5.3 Alomone Labs AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alomone Labs AQP4 Antibody Product Portfolio
6.5.5 Alomone Labs Recent Developments/Updates
6.6 Synaptic Systems
6.6.1 Synaptic Systems Company Information
6.6.2 Synaptic Systems Description and Business Overview
6.6.3 Synaptic Systems AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synaptic Systems AQP4 Antibody Product Portfolio
6.6.5 Synaptic Systems Recent Developments/Updates
6.7 St John's Laboratory
6.7.1 St John's Laboratory Company Information
6.7.2 St John's Laboratory Description and Business Overview
6.7.3 St John's Laboratory AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 St John's Laboratory AQP4 Antibody Product Portfolio
6.7.5 St John's Laboratory Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Company Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abcam AQP4 Antibody Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 Cell Signaling Technology
6.9.1 Cell Signaling Technology Company Information
6.9.2 Cell Signaling Technology Description and Business Overview
6.9.3 Cell Signaling Technology AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cell Signaling Technology AQP4 Antibody Product Portfolio
6.9.5 Cell Signaling Technology Recent Developments/Updates
6.10 ABclonal
6.10.1 ABclonal Company Information
6.10.2 ABclonal Description and Business Overview
6.10.3 ABclonal AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ABclonal AQP4 Antibody Product Portfolio
6.10.5 ABclonal Recent Developments/Updates
6.11 Nordic BioSite
6.11.1 Nordic BioSite Company Information
6.11.2 Nordic BioSite Description and Business Overview
6.11.3 Nordic BioSite AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nordic BioSite AQP4 Antibody Product Portfolio
6.11.5 Nordic BioSite Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck AQP4 Antibody Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 LifeSpan BioSciences
6.13.1 LifeSpan BioSciences Company Information
6.13.2 LifeSpan BioSciences Description and Business Overview
6.13.3 LifeSpan BioSciences AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 LifeSpan BioSciences AQP4 Antibody Product Portfolio
6.13.5 LifeSpan BioSciences Recent Developments/Updates
6.14 Bioss
6.14.1 Bioss Company Information
6.14.2 Bioss Description and Business Overview
6.14.3 Bioss AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bioss AQP4 Antibody Product Portfolio
6.14.5 Bioss Recent Developments/Updates
6.15 Novus Biologicals
6.15.1 Novus Biologicals Company Information
6.15.2 Novus Biologicals Description and Business Overview
6.15.3 Novus Biologicals AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Novus Biologicals AQP4 Antibody Product Portfolio
6.15.5 Novus Biologicals Recent Developments/Updates
6.16 RayBiotech
6.16.1 RayBiotech Company Information
6.16.2 RayBiotech Description and Business Overview
6.16.3 RayBiotech AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RayBiotech AQP4 Antibody Product Portfolio
6.16.5 RayBiotech Recent Developments/Updates
6.17 Abnova Corporation
6.17.1 Abnova Corporation Company Information
6.17.2 Abnova Corporation Description and Business Overview
6.17.3 Abnova Corporation AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Abnova Corporation AQP4 Antibody Product Portfolio
6.17.5 Abnova Corporation Recent Developments/Updates
6.18 Beijing Solarbio
6.18.1 Beijing Solarbio Company Information
6.18.2 Beijing Solarbio Description and Business Overview
6.18.3 Beijing Solarbio AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Solarbio AQP4 Antibody Product Portfolio
6.18.5 Beijing Solarbio Recent Developments/Updates
6.19 Jingjie PTM BioLab
6.19.1 Jingjie PTM BioLab Company Information
6.19.2 Jingjie PTM BioLab Description and Business Overview
6.19.3 Jingjie PTM BioLab AQP4 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jingjie PTM BioLab AQP4 Antibody Product Portfolio
6.19.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 AQP4 Antibody Industry Chain Analysis
7.2 AQP4 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 AQP4 Antibody Production Mode & Process Analysis
7.4 AQP4 Antibody Sales and Marketing
7.4.1 AQP4 Antibody Sales Channels
7.4.2 AQP4 Antibody Distributors
7.5 AQP4 Antibody Customer Analysis
8 AQP4 Antibody Market Dynamics
8.1 AQP4 Antibody Industry Trends
8.2 AQP4 Antibody Market Drivers
8.3 AQP4 Antibody Market Challenges
8.4 AQP4 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global AQP4 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global AQP4 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global AQP4 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global AQP4 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global AQP4 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global AQP4 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global AQP4 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market AQP4 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of AQP4 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of AQP4 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of AQP4 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of AQP4 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global AQP4 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AQP4 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global AQP4 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global AQP4 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global AQP4 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global AQP4 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global AQP4 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global AQP4 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global AQP4 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global AQP4 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global AQP4 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific AQP4 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific AQP4 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific AQP4 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific AQP4 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific AQP4 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global AQP4 Antibody Sales (L) by Type (2020-2025)
Table 51. Global AQP4 Antibody Sales (L) by Type (2026-2031)
Table 52. Global AQP4 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global AQP4 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global AQP4 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global AQP4 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global AQP4 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global AQP4 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global AQP4 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global AQP4 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global AQP4 Antibody Sales (L) by Application (2020-2025)
Table 61. Global AQP4 Antibody Sales (L) by Application (2026-2031)
Table 62. Global AQP4 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global AQP4 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global AQP4 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global AQP4 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global AQP4 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global AQP4 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global AQP4 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global AQP4 Antibody Price (US$/L) by Application (2026-2031)
Table 70. Atlas Antibodies Company Information
Table 71. Atlas Antibodies Description and Business Overview
Table 72. Atlas Antibodies AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Atlas Antibodies AQP4 Antibody Product
Table 74. Atlas Antibodies Recent Developments/Updates
Table 75. Boster Bio Company Information
Table 76. Boster Bio Description and Business Overview
Table 77. Boster Bio AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Boster Bio AQP4 Antibody Product
Table 79. Boster Bio Recent Developments/Updates
Table 80. Absolute Antibody Company Information
Table 81. Absolute Antibody Description and Business Overview
Table 82. Absolute Antibody AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Absolute Antibody AQP4 Antibody Product
Table 84. Absolute Antibody Recent Developments/Updates
Table 85. VWR Company Information
Table 86. VWR Description and Business Overview
Table 87. VWR AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. VWR AQP4 Antibody Product
Table 89. VWR Recent Developments/Updates
Table 90. Alomone Labs Company Information
Table 91. Alomone Labs Description and Business Overview
Table 92. Alomone Labs AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Alomone Labs AQP4 Antibody Product
Table 94. Alomone Labs Recent Developments/Updates
Table 95. Synaptic Systems Company Information
Table 96. Synaptic Systems Description and Business Overview
Table 97. Synaptic Systems AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Synaptic Systems AQP4 Antibody Product
Table 99. Synaptic Systems Recent Developments/Updates
Table 100. St John's Laboratory Company Information
Table 101. St John's Laboratory Description and Business Overview
Table 102. St John's Laboratory AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. St John's Laboratory AQP4 Antibody Product
Table 104. St John's Laboratory Recent Developments/Updates
Table 105. Abcam Company Information
Table 106. Abcam Description and Business Overview
Table 107. Abcam AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Abcam AQP4 Antibody Product
Table 109. Abcam Recent Developments/Updates
Table 110. Cell Signaling Technology Company Information
Table 111. Cell Signaling Technology Description and Business Overview
Table 112. Cell Signaling Technology AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Cell Signaling Technology AQP4 Antibody Product
Table 114. Cell Signaling Technology Recent Developments/Updates
Table 115. ABclonal Company Information
Table 116. ABclonal Description and Business Overview
Table 117. ABclonal AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. ABclonal AQP4 Antibody Product
Table 119. ABclonal Recent Developments/Updates
Table 120. Nordic BioSite Company Information
Table 121. Nordic BioSite Description and Business Overview
Table 122. Nordic BioSite AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Nordic BioSite AQP4 Antibody Product
Table 124. Nordic BioSite Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. Merck AQP4 Antibody Product
Table 129. Merck Recent Developments/Updates
Table 130. LifeSpan BioSciences Company Information
Table 131. LifeSpan BioSciences Description and Business Overview
Table 132. LifeSpan BioSciences AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. LifeSpan BioSciences AQP4 Antibody Product
Table 134. LifeSpan BioSciences Recent Developments/Updates
Table 135. Bioss Company Information
Table 136. Bioss Description and Business Overview
Table 137. Bioss AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. Bioss AQP4 Antibody Product
Table 139. Bioss Recent Developments/Updates
Table 140. Novus Biologicals Company Information
Table 141. Novus Biologicals Description and Business Overview
Table 142. Novus Biologicals AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Novus Biologicals AQP4 Antibody Product
Table 144. Novus Biologicals Recent Developments/Updates
Table 145. RayBiotech Company Information
Table 146. RayBiotech Description and Business Overview
Table 147. RayBiotech AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. RayBiotech AQP4 Antibody Product
Table 149. RayBiotech Recent Developments/Updates
Table 150. Abnova Corporation Company Information
Table 151. Abnova Corporation Description and Business Overview
Table 152. Abnova Corporation AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Abnova Corporation AQP4 Antibody Product
Table 154. Abnova Corporation Recent Developments/Updates
Table 155. Beijing Solarbio Company Information
Table 156. Beijing Solarbio Description and Business Overview
Table 157. Beijing Solarbio AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Beijing Solarbio AQP4 Antibody Product
Table 159. Beijing Solarbio Recent Developments/Updates
Table 160. Jingjie PTM BioLab Company Information
Table 161. Jingjie PTM BioLab Description and Business Overview
Table 162. Jingjie PTM BioLab AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. Jingjie PTM BioLab AQP4 Antibody Product
Table 164. Jingjie PTM BioLab Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. AQP4 Antibody Distributors List
Table 168. AQP4 Antibody Customers List
Table 169. AQP4 Antibody Market Trends
Table 170. AQP4 Antibody Market Drivers
Table 171. AQP4 Antibody Market Challenges
Table 172. AQP4 Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of AQP4 Antibody
Figure 2. Global AQP4 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AQP4 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global AQP4 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global AQP4 Antibody Market Share by Application: 2024 & 2031
Figure 8. Western Blot (WB)
Figure 9. Immunochemistry (IHC)
Figure 10. Immunoprecipitation (IP)
Figure 11. Immunocytochemistry (ICC)
Figure 12. Others
Figure 13. Global AQP4 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global AQP4 Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global AQP4 Antibody Sales (2020-2031) & (L)
Figure 16. Global AQP4 Antibody Average Price (US$/L) & (2020-2031)
Figure 17. AQP4 Antibody Report Years Considered
Figure 18. AQP4 Antibody Sales Share by Manufacturers in 2024
Figure 19. Global AQP4 Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest AQP4 Antibody Players: Market Share by Revenue in AQP4 Antibody in 2024
Figure 21. AQP4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global AQP4 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific AQP4 Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific AQP4 Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of AQP4 Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of AQP4 Antibody by Type (2020-2031)
Figure 55. Global AQP4 Antibody Price (US$/L) by Type (2020-2031)
Figure 56. Global Sales Market Share of AQP4 Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of AQP4 Antibody by Application (2020-2031)
Figure 58. Global AQP4 Antibody Price (US$/L) by Application (2020-2031)
Figure 59. AQP4 Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global AQP4 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global AQP4 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global AQP4 Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global AQP4 Antibody Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global AQP4 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global AQP4 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global AQP4 Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market AQP4 Antibody Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of AQP4 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of AQP4 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of AQP4 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of AQP4 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global AQP4 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AQP4 Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global AQP4 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global AQP4 Antibody Sales by Region (2020-2025) & (L)
Table 18. Global AQP4 Antibody Sales Market Share by Region (2020-2025)
Table 19. Global AQP4 Antibody Sales by Region (2026-2031) & (L)
Table 20. Global AQP4 Antibody Sales Market Share by Region (2026-2031)
Table 21. Global AQP4 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global AQP4 Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global AQP4 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global AQP4 Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 27. North America AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 28. North America AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 32. Europe AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 33. Europe AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific AQP4 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific AQP4 Antibody Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific AQP4 Antibody Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific AQP4 Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific AQP4 Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 42. Latin America AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 43. Latin America AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa AQP4 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa AQP4 Antibody Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa AQP4 Antibody Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa AQP4 Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa AQP4 Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global AQP4 Antibody Sales (L) by Type (2020-2025)
Table 51. Global AQP4 Antibody Sales (L) by Type (2026-2031)
Table 52. Global AQP4 Antibody Sales Market Share by Type (2020-2025)
Table 53. Global AQP4 Antibody Sales Market Share by Type (2026-2031)
Table 54. Global AQP4 Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global AQP4 Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global AQP4 Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global AQP4 Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global AQP4 Antibody Price (US$/L) by Type (2020-2025)
Table 59. Global AQP4 Antibody Price (US$/L) by Type (2026-2031)
Table 60. Global AQP4 Antibody Sales (L) by Application (2020-2025)
Table 61. Global AQP4 Antibody Sales (L) by Application (2026-2031)
Table 62. Global AQP4 Antibody Sales Market Share by Application (2020-2025)
Table 63. Global AQP4 Antibody Sales Market Share by Application (2026-2031)
Table 64. Global AQP4 Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global AQP4 Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global AQP4 Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global AQP4 Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global AQP4 Antibody Price (US$/L) by Application (2020-2025)
Table 69. Global AQP4 Antibody Price (US$/L) by Application (2026-2031)
Table 70. Atlas Antibodies Company Information
Table 71. Atlas Antibodies Description and Business Overview
Table 72. Atlas Antibodies AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Atlas Antibodies AQP4 Antibody Product
Table 74. Atlas Antibodies Recent Developments/Updates
Table 75. Boster Bio Company Information
Table 76. Boster Bio Description and Business Overview
Table 77. Boster Bio AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Boster Bio AQP4 Antibody Product
Table 79. Boster Bio Recent Developments/Updates
Table 80. Absolute Antibody Company Information
Table 81. Absolute Antibody Description and Business Overview
Table 82. Absolute Antibody AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Absolute Antibody AQP4 Antibody Product
Table 84. Absolute Antibody Recent Developments/Updates
Table 85. VWR Company Information
Table 86. VWR Description and Business Overview
Table 87. VWR AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 88. VWR AQP4 Antibody Product
Table 89. VWR Recent Developments/Updates
Table 90. Alomone Labs Company Information
Table 91. Alomone Labs Description and Business Overview
Table 92. Alomone Labs AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 93. Alomone Labs AQP4 Antibody Product
Table 94. Alomone Labs Recent Developments/Updates
Table 95. Synaptic Systems Company Information
Table 96. Synaptic Systems Description and Business Overview
Table 97. Synaptic Systems AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 98. Synaptic Systems AQP4 Antibody Product
Table 99. Synaptic Systems Recent Developments/Updates
Table 100. St John's Laboratory Company Information
Table 101. St John's Laboratory Description and Business Overview
Table 102. St John's Laboratory AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 103. St John's Laboratory AQP4 Antibody Product
Table 104. St John's Laboratory Recent Developments/Updates
Table 105. Abcam Company Information
Table 106. Abcam Description and Business Overview
Table 107. Abcam AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 108. Abcam AQP4 Antibody Product
Table 109. Abcam Recent Developments/Updates
Table 110. Cell Signaling Technology Company Information
Table 111. Cell Signaling Technology Description and Business Overview
Table 112. Cell Signaling Technology AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 113. Cell Signaling Technology AQP4 Antibody Product
Table 114. Cell Signaling Technology Recent Developments/Updates
Table 115. ABclonal Company Information
Table 116. ABclonal Description and Business Overview
Table 117. ABclonal AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 118. ABclonal AQP4 Antibody Product
Table 119. ABclonal Recent Developments/Updates
Table 120. Nordic BioSite Company Information
Table 121. Nordic BioSite Description and Business Overview
Table 122. Nordic BioSite AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 123. Nordic BioSite AQP4 Antibody Product
Table 124. Nordic BioSite Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 128. Merck AQP4 Antibody Product
Table 129. Merck Recent Developments/Updates
Table 130. LifeSpan BioSciences Company Information
Table 131. LifeSpan BioSciences Description and Business Overview
Table 132. LifeSpan BioSciences AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 133. LifeSpan BioSciences AQP4 Antibody Product
Table 134. LifeSpan BioSciences Recent Developments/Updates
Table 135. Bioss Company Information
Table 136. Bioss Description and Business Overview
Table 137. Bioss AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 138. Bioss AQP4 Antibody Product
Table 139. Bioss Recent Developments/Updates
Table 140. Novus Biologicals Company Information
Table 141. Novus Biologicals Description and Business Overview
Table 142. Novus Biologicals AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 143. Novus Biologicals AQP4 Antibody Product
Table 144. Novus Biologicals Recent Developments/Updates
Table 145. RayBiotech Company Information
Table 146. RayBiotech Description and Business Overview
Table 147. RayBiotech AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 148. RayBiotech AQP4 Antibody Product
Table 149. RayBiotech Recent Developments/Updates
Table 150. Abnova Corporation Company Information
Table 151. Abnova Corporation Description and Business Overview
Table 152. Abnova Corporation AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 153. Abnova Corporation AQP4 Antibody Product
Table 154. Abnova Corporation Recent Developments/Updates
Table 155. Beijing Solarbio Company Information
Table 156. Beijing Solarbio Description and Business Overview
Table 157. Beijing Solarbio AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 158. Beijing Solarbio AQP4 Antibody Product
Table 159. Beijing Solarbio Recent Developments/Updates
Table 160. Jingjie PTM BioLab Company Information
Table 161. Jingjie PTM BioLab Description and Business Overview
Table 162. Jingjie PTM BioLab AQP4 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 163. Jingjie PTM BioLab AQP4 Antibody Product
Table 164. Jingjie PTM BioLab Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. AQP4 Antibody Distributors List
Table 168. AQP4 Antibody Customers List
Table 169. AQP4 Antibody Market Trends
Table 170. AQP4 Antibody Market Drivers
Table 171. AQP4 Antibody Market Challenges
Table 172. AQP4 Antibody Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of AQP4 Antibody
Figure 2. Global AQP4 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AQP4 Antibody Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global AQP4 Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global AQP4 Antibody Market Share by Application: 2024 & 2031
Figure 8. Western Blot (WB)
Figure 9. Immunochemistry (IHC)
Figure 10. Immunoprecipitation (IP)
Figure 11. Immunocytochemistry (ICC)
Figure 12. Others
Figure 13. Global AQP4 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global AQP4 Antibody Market Size (2020-2031) & (US$ Million)
Figure 15. Global AQP4 Antibody Sales (2020-2031) & (L)
Figure 16. Global AQP4 Antibody Average Price (US$/L) & (2020-2031)
Figure 17. AQP4 Antibody Report Years Considered
Figure 18. AQP4 Antibody Sales Share by Manufacturers in 2024
Figure 19. Global AQP4 Antibody Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest AQP4 Antibody Players: Market Share by Revenue in AQP4 Antibody in 2024
Figure 21. AQP4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global AQP4 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 24. North America AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 25. United States AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 28. Europe AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 29. Germany AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific AQP4 Antibody Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific AQP4 Antibody Revenue Market Share by Region (2020-2031)
Figure 36. China AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa AQP4 Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa AQP4 Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE AQP4 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of AQP4 Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of AQP4 Antibody by Type (2020-2031)
Figure 55. Global AQP4 Antibody Price (US$/L) by Type (2020-2031)
Figure 56. Global Sales Market Share of AQP4 Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of AQP4 Antibody by Application (2020-2031)
Figure 58. Global AQP4 Antibody Price (US$/L) by Application (2020-2031)
Figure 59. AQP4 Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232